February 27, 2018 Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast. Cowen and Company Annual Health Care Conference, Boston, MA on March 13, 2018 at 10:40 am Eastern Time. The webcast can be accessed in the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com. About... Read more

January 8, 2018 Environ, Ag./Food & Bev Lab Top-10 Life Science Tools Microscopy Product Launch

Illumina Launches iSeq 100 Sequencing System

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System. The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab. The combination of the company’s proven sequencing by synthesis (SBS) chemistry, along with the complementary metal-oxide-semiconductor... Read more

January 8, 2018 Atomic Spectroscopy Environ, Ag./Food & Bev Lab Top-10 Liq. Handling & Robotics M&A, Partnerships

Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology

Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas Thermo Fisher Scientific and Illumina, Inc.(NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct... Read more

December 19, 2017 Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Illumina to Webcast Upcoming Investor Conference Presentations

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be presenting at the following investor conference and invited investors to participate via webcast. J.P. Morgan Healthcare Conference Presentation, San Francisco, CaliforniaMonday, January 8, 2018 at 3:30 pm Pacific Time J.P. Morgan Healthcare Conference Question & Answer Session, San Francisco, CaliforniaMonday, January 8, 2018 at... Read more

November 22, 2017 Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast. Citi Global Healthcare Conference, New York, NY on December 7, 2017 at 11:45 am Eastern Time. The webcast can be accessed in the Investor Relations section of Illumina’s web site under... Read more

November 21, 2017 Acad, Gov/Utilities Chromatography Clinical Research/Diagn. Environ, Ag./Food & Bev Lab Top-10 Licensing, IP, and Legal

Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al. and the patent infringement suit filed against Ariosa Diagnostics, Inc., et al. The Court found... Read more

November 15, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Illumina Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550Dx System and Expanded Use of MiSeq™Dx System

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the introduction of its NextSeq™ 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system. The company also announced that the intended use for the MiSeq™Dx instrument has been updated to include the use of DNA libraries generated from formalin-fixed paraffin embedded (FFPE) tissues,... Read more

November 8, 2017 Lab Top-10 Life Science Tools PR/Corporate

Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S. Guthart will join the company’s Board of Directors on December 1, 2017. Dr. Guthart is President and Chief Executive Officer of Intuitive Surgical, a global leader in the field of robotic-assisted minimally invasive surgery. Dr. Guthart joined Intuitive Surgical in April 1996 and has served... Read more

September 7, 2017 Acad, Gov/Utilities Chromatography Environ, Ag./Food & Bev Lab Top-10 Licensing, IP, and Legal Product Launch

Illumina Files New Patent Infringement Suit Against Premaitha Health plc

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom. Illumina is seeking all available remedies, including damages and injunctive relief. The new suit accuses Premaitha’s IONA® Test of infringing... Read more